1707 — Grape King Bio Share Price
0.000.00%
Last trade - 00:00- TWD23.55bn
- TWD20.43bn
- TWD10.64bn
- 88
- 62
- 50
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.66 | ||
| PEG Ratio (f) | 1.88 | ||
| EPS Growth (f) | 8.46% | ||
| Dividend Yield (f) | 4.69% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.36 | ||
| Price to Tang. Book | 2.39 | ||
| Price to Free Cashflow | 12.28 | ||
| Price to Sales | 2.21 | ||
| EV to EBITDA | 6.93 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 21.04% | ||
| Return on Equity | 14.86% | ||
| Operating Margin | 23.47% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 9,239.07 | 9,168.19 | 9,798.25 | 10,391.23 | 10,635.46 | 11,518.06 | 12,139.34 | 2.98% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +0.76 | -3.06 | -5.7 | +11.7 | -0.44 | +9.18 | +6.83 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Grape King Bio Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of healthcare products and beverages. The company operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The Company operates in Taiwan, mainland China and other markets.
Directors
- Andrew Tseng CHM
- Nick Hung CFO
- Jin-Chu Chen DGM
- Yuan-Tsung Lin DGM
- Chih-Lin Hung OTH
- Zhijia Chang DRC
- Xingjun Chen DRC
- Yanxiang Huang DRC
- Shiow-Ling Kao DRC
- Zhiwei Lai DRC
- Mei-Ching Tseng DRC
- Sheng-Bin Tseng DRC
- Zhisheng Zhang DRC
- Ching-Fu Chen IND
- Jingning Chen IND
- Fengyi Lin IND
- Yifan Miao IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 1st, 1971
- Public Since
- December 20th, 1982
- No. of Employees
- 501
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 148,137,000
- Address
- No. 60, Section 3, Lung-Kang Road, TAOYUAN, 324
- Web
- https://www.grapeking.com.tw/
- Phone
- +886 34572121
- Contact
- Nick Hung
- Auditors
- Deloitte & Touche LLP
Upcoming Events for 1707
April 2024 Grape King Bio Ltd Corporate Sales Release
Grape King Bio Ltd Annual Shareholders Meeting
Grape King Bio Ltd Annual Shareholders Meeting
May 2024 Grape King Bio Ltd Corporate Sales Release
Q2 2024 Grape King Bio Ltd Earnings Release
Similar to 1707
AGV Products
Taiwan Stock Exchange
Charoen Pokphand Enterprise Taiwan Co
Taiwan Stock Exchange
Formosa Oilseed Processing Co
Taiwan Stock Exchange
Fwusow Industry Co
Taiwan Stock Exchange
GenMont Biotech
Taiwan Stock Exchange
FAQ
What is the Grape King Bio share price?
As of Today at 19:09 UTC, shares in Grape King Bio are trading at TWD159.00. This share price information is delayed by 15 minutes.
How has the Grape King Bio share price performed this year?
Shares in Grape King Bio last closed at TWD159.00 and the price had moved by -14.52% over the past 365 days. In terms of relative price strength the Grape King Bio share price has underperformed the FTSE Developed Asia Pacific Index by -13.93% over the past year.
What are the analyst and broker recommendations for Grape King Bio?
The overall consensus recommendation for Grape King Bio is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Grape King Bio dividend yield?
The Grape King Bio dividend yield is 4.34% based on the trailing twelve month period.
Does Grape King Bio pay a dividend?
Last year, Grape King Bio paid a total dividend of TWD6.90, and it currently has a trailing dividend yield of 4.34%. We do not have any data on when Grape King Bio is to next pay dividends.
When does Grape King Bio next pay dividends?
We do not have data on when Grape King Bio is to next pay dividends. The historic dividend yield on Grape King Bio shares is currently 4.34%.
How do I buy Grape King Bio shares?
To buy shares in Grape King Bio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Grape King Bio?
As of the previous close price of TWD159.00, shares in Grape King Bio had a market capitalisation of TWD23.55bn.
Where are Grape King Bio shares listed?
Here are the trading details for Grape King Bio:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 1707
What kind of share is Grape King Bio?
Based on an overall assessment of its quality, value and momentum Grape King Bio is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Grape King Bio share price forecast for 2024?
The analyst consensus target price for shares in Grape King Bio is TWD165.00. That is 3.77% above the last closing price of TWD159.00.
Analysts covering Grape King Bio currently have a consensus Earnings Per Share (EPS) forecast of TWD10.64 for the next financial year.
What is the trend in the Grape King Bio share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Grape King Bio. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -3.88%.
As of the last closing price of TWD159.00, shares in Grape King Bio were trading +0.78% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Grape King Bio PE Ratio?
The Grape King Bio PE ratio based on its reported earnings over the past 12 months is 14.66. The shares last closed at TWD159.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Grape King Bio?
Grape King Bio's management team is headed by:
- Andrew Tseng - CHM
- Nick Hung - CFO
- Jin-Chu Chen - DGM
- Yuan-Tsung Lin - DGM
- Chih-Lin Hung - OTH
- Zhijia Chang - DRC
- Xingjun Chen - DRC
- Yanxiang Huang - DRC
- Shiow-Ling Kao - DRC
- Zhiwei Lai - DRC
- Mei-Ching Tseng - DRC
- Sheng-Bin Tseng - DRC
- Zhisheng Zhang - DRC
- Ching-Fu Chen - IND
- Jingning Chen - IND
- Fengyi Lin - IND
- Yifan Miao - IND